These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 20464672

  • 1. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty.
    Salapura V, Blinc A, Kozak M, Jezovnik MK, Pohar Perme M, Berden P, Kuhelj D, Kljucevsek T, Popovic P, Stankovic M, Vrtovec M, Surlan M.
    Vasa; 2010 May; 39(2):159-68. PubMed ID: 20464672
    [Abstract] [Full Text] [Related]

  • 2. Revascularization by angioplasty of type D femoropopliteal and long infrapopliteal lesion in diabetic patients with critical limb ischemia: are TASC II recommendations suitable? A population-based cohort study.
    Faglia E, Clerici G, Airoldi F, Tavano D, Caminiti M, Curci V, Mantero M, Morabito A, Edmonds M.
    Int J Low Extrem Wounds; 2012 Dec; 11(4):277-85. PubMed ID: 23089965
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosis.
    Werner M, Scheinert D, Henn M, Scheinert S, Bräunlich S, Bausback Y, Friedenberger J, Schuster J, Hertting K, Piorkowski M, Rosner C, Schmidt A, Ulrich M, Gutberlet M.
    J Endovasc Ther; 2012 Aug; 19(4):467-75. PubMed ID: 22891824
    [Abstract] [Full Text] [Related]

  • 5. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R, Spring S, Amann-Vesti BR, Meier T, Pfammatter T, Rousson V, Banyai M, van der Loo B.
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
    Dippel EJ, Makam P, Kovach R, George JC, Patlola R, Metzger DC, Mena-Hurtado C, Beasley R, Soukas P, Colon-Hernandez PJ, Stark MA, Walker C, EXCITE ISR Investigators.
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF, Mezzetto L, Macrì M, Criscenti P, Corvasce A, Poli R.
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [Abstract] [Full Text] [Related]

  • 8. Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females?
    Maca T, Ahmadi R, Derfler K, Hörl WH, Koppensteiner R, Minar E, Schneider B, Stümpflen A, Ehringer H.
    Atherosclerosis; 1996 Nov 15; 127(1):27-34. PubMed ID: 9006801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S, Ghanian S, Parikh SA, Secemsky EA, Schneider PA, Armstrong EJ.
    J Endovasc Ther; 2020 Aug 15; 27(4):647-657. PubMed ID: 32508220
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F, Fisicaro M, Calderan L, Malacrea M, Mazzone C, Cattin L, Scardi S, Pozzi Mucelli R.
    Radiol Med; 2003 Apr 15; 105(4):339-49. PubMed ID: 12835627
    [Abstract] [Full Text] [Related]

  • 16. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Yokoi H, Tosaka A, Tanaka N, Iida O.
    J Endovasc Ther; 2016 Aug 15; 23(4):642-7. PubMed ID: 27099284
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
    Radak Dj, Laps KH, Jeger KA, Ilijevski N, Vojić M.
    Srp Arh Celok Lek; 1998 Aug 15; 126(3-4):83-91. PubMed ID: 9863361
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T, Beschorner U, Pilger E, Bosiers M, Deloose K, Peeters P, Scheinert D, Schulte KL, Rastan A, Brodmann M.
    JACC Cardiovasc Interv; 2015 Oct 15; 8(12):1614-22. PubMed ID: 26493253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.